The latest price target for Global Medical REIT (NYSE: GMRE) was reported by B. Riley Securities on May 8, 2023. The analyst firm set a price target for $11.00 expecting GMRE to rise to within 12 months (a possible 22.09% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Global Medical REIT (NYSE: GMRE) was provided by B. Riley Securities, and Global Medical REIT maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Global Medical REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Global Medical REIT was filed on May 8, 2023 so you should expect the next rating to be made available sometime around May 8, 2024.

While ratings are subjective and will change, the latest Global Medical REIT (GMRE) rating was a maintained with a price target of $12.00 to $11.00. The current price Global Medical REIT (GMRE) is trading at is $9.01, which is out of the analyst’s predicted range.

The latest price target for Global Medical REIT (NYSE: GMRE) was reported by B. Riley Securities on May 8, 2023. The analyst firm set a price target for $11.00 expecting GMRE to rise to within 12 months (a possible 22.09% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Global Medical REIT (NYSE: GMRE) was provided by B. Riley Securities, and Global Medical REIT maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Global Medical REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Global Medical REIT was filed on May 8, 2023 so you should expect the next rating to be made available sometime around May 8, 2024.

While ratings are subjective and will change, the latest Global Medical REIT (GMRE) rating was a maintained with a price target of $12.00 to $11.00. The current price Global Medical REIT (GMRE) is trading at is $9.01, which is out of the analyst’s predicted range.

The latest price target for Global Medical REIT (NYSE: GMRE) was reported by B. Riley Securities on May 8, 2023. The analyst firm set a price target for $11.00 expecting GMRE to rise to within 12 months (a possible 22.09% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Global Medical REIT (NYSE: GMRE) was provided by B. Riley Securities, and Global Medical REIT maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Global Medical REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Global Medical REIT was filed on May 8, 2023 so you should expect the next rating to be made available sometime around May 8, 2024.

While ratings are subjective and will change, the latest Global Medical REIT (GMRE) rating was a maintained with a price target of $12.00 to $11.00. The current price Global Medical REIT (GMRE) is trading at is $9.01, which is out of the analyst’s predicted range.

The latest price target for Global Medical REIT (NYSE: GMRE) was reported by B. Riley Securities on May 8, 2023. The analyst firm set a price target for $11.00 expecting GMRE to rise to within 12 months (a possible 22.09% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Global Medical REIT (NYSE: GMRE) was provided by B. Riley Securities, and Global Medical REIT maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Global Medical REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Global Medical REIT was filed on May 8, 2023 so you should expect the next rating to be made available sometime around May 8, 2024.

While ratings are subjective and will change, the latest Global Medical REIT (GMRE) rating was a maintained with a price target of $12.00 to $11.00. The current price Global Medical REIT (GMRE) is trading at is $9.01, which is out of the analyst’s predicted range.

The latest price target for Global Medical REIT (NYSE: GMRE) was reported by B. Riley Securities on May 8, 2023. The analyst firm set a price target for $11.00 expecting GMRE to rise to within 12 months (a possible 22.09% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Global Medical REIT (NYSE: GMRE) was provided by B. Riley Securities, and Global Medical REIT maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Global Medical REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Global Medical REIT was filed on May 8, 2023 so you should expect the next rating to be made available sometime around May 8, 2024.

While ratings are subjective and will change, the latest Global Medical REIT (GMRE) rating was a maintained with a price target of $12.00 to $11.00. The current price Global Medical REIT (GMRE) is trading at is $9.01, which is out of the analyst’s predicted range.

The latest price target for Global Medical REIT (NYSE: GMRE) was reported by B. Riley Securities on May 8, 2023. The analyst firm set a price target for $11.00 expecting GMRE to rise to within 12 months (a possible 22.09% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Global Medical REIT (NYSE: GMRE) was provided by B. Riley Securities, and Global Medical REIT maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Global Medical REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Global Medical REIT was filed on May 8, 2023 so you should expect the next rating to be made available sometime around May 8, 2024.

While ratings are subjective and will change, the latest Global Medical REIT (GMRE) rating was a maintained with a price target of $12.00 to $11.00. The current price Global Medical REIT (GMRE) is trading at is $9.01, which is out of the analyst’s predicted range.

The latest price target for Global Medical REIT (NYSE: GMRE) was reported by B. Riley Securities on May 8, 2023. The analyst firm set a price target for $11.00 expecting GMRE to rise to within 12 months (a possible 22.09% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Global Medical REIT (NYSE: GMRE) was provided by B. Riley Securities, and Global Medical REIT maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Global Medical REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Global Medical REIT was filed on May 8, 2023 so you should expect the next rating to be made available sometime around May 8, 2024.

While ratings are subjective and will change, the latest Global Medical REIT (GMRE) rating was a maintained with a price target of $12.00 to $11.00. The current price Global Medical REIT (GMRE) is trading at is $9.01, which is out of the analyst’s predicted range.

The latest price target for Global Medical REIT (NYSE: GMRE) was reported by B. Riley Securities on May 8, 2023. The analyst firm set a price target for $11.00 expecting GMRE to rise to within 12 months (a possible 22.09% upside). 4 analyst firms have reported ratings in the last year.

The latest analyst rating for Global Medical REIT (NYSE: GMRE) was provided by B. Riley Securities, and Global Medical REIT maintained their buy rating.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Global Medical REIT, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Global Medical REIT was filed on May 8, 2023 so you should expect the next rating to be made available sometime around May 8, 2024.

While ratings are subjective and will change, the latest Global Medical REIT (GMRE) rating was a maintained with a price target of $12.00 to $11.00. The current price Global Medical REIT (GMRE) is trading at is $9.01, which is out of the analyst’s predicted range.